Clinical Trials

2 studies in Hepatitis C

1. Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin Scottsdale and Phoenix, AZ View Summary
   Close

   Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin

   Location:

   Scottsdale and Phoenix, AZ

   Trial status:

   Open for Enrollment

   Why is this study being done?

   Study Classification: Pharmacokinetics/ Pharmacodynamics

   NCT ID:

   NCT01309932

   • Print Summary
   • View study details

   Who can I contact for additional information about this study?

   
   Scottsdale: Hugo E Vargas, Site 040 480-342-1096
                       
   
   

2. Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial Rochester, MN View Summary
   Close

   Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial

   Location:

   Rochester, MN

   Trial status:

   Open for Enrollment

   Why is this study being done?

   The primary purpose of this study is to determine whether the hepatitis C virus continues to remain unable to be detected in subjects who were previously treated with BMS-914143 and achieved sustained virologic response

   NCT ID:

   NCT01525810

   • Print Summary
   • View study details

   Who can I contact for additional information about this study?

   Rochester: Michael Charlton, Site 012 507-284-2511